Lucid Diagnostics Inc. - Common Stock (LUCD)
1.4700
+0.0500 (3.52%)
NASDAQ · Last Trade: Apr 3rd, 1:31 AM EDT
Detailed Quote
Previous Close | 1.420 |
---|---|
Open | 1.410 |
Bid | 1.360 |
Ask | 1.450 |
Day's Range | 1.380 - 1.480 |
52 Week Range | 0.6301 - 1.633 |
Volume | 503,564 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 868,842 |
About Lucid Diagnostics Inc. - Common Stock (LUCD)
Lucid Diagnostics Inc is a technology company focused on advancing the field of diagnostic solutions in healthcare. It specializes in the development and commercialization of innovative medical devices and diagnostic tests aimed at improving patient outcomes and streamlining the detection of various diseases, particularly in the gastrointestinal sector. The company is committed to creating impactful tools that enhance the efficiency and accuracy of disease diagnosis, thereby supporting healthcare professionals in delivering better care to patients. Its portfolio includes both proprietary technologies and collaborations aimed at bringing cutting-edge diagnostics to the market. Read More
News & Press Releases

Via Benzinga · December 9, 2024

Via Benzinga · October 8, 2024

Via Benzinga · March 15, 2023

Penny stocks are a risky but potentially rewarding opportunity for investors willing to take on their uncertainty; these stocks may stand out from the pack.
Via MarketBeat · October 4, 2024

LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 12, 2024

While a high-risk proposition, these hypergrowth stocks can potentially bring enormous returns in a short period of time.
Via InvestorPlace · July 29, 2024

Although the concept of penny stocks to buy is extremely risky, these ideas have the advantage of analysts’ positive assessments.
Via InvestorPlace · May 20, 2024

LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 13, 2024

Via Benzinga · April 30, 2024

Via Benzinga · April 29, 2024

Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here.
Via InvestorPlace · April 19, 2024

LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 25, 2024

Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on revenue of $161.50 million.
Via Benzinga · March 25, 2024

Via Benzinga · February 19, 2024

Via Benzinga · January 18, 2024

Via Benzinga · March 24, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via Benzinga · November 13, 2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via Benzinga · August 14, 2023